TRIMIPRAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trimipramine Maleate, and when can generic versions of Trimipramine Maleate launch?
Trimipramine Maleate is a drug marketed by Breckenridge, Elite Labs Inc, and Usl Pharma. and is included in five NDAs.
The generic ingredient in TRIMIPRAMINE MALEATE is trimipramine maleate. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trimipramine Maleate
A generic version of TRIMIPRAMINE MALEATE was approved as trimipramine maleate by ELITE LABS INC on August 2nd, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIMIPRAMINE MALEATE?
- What are the global sales for TRIMIPRAMINE MALEATE?
- What is Average Wholesale Price for TRIMIPRAMINE MALEATE?
Summary for TRIMIPRAMINE MALEATE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Patent Applications: | 654 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIMIPRAMINE MALEATE |
DailyMed Link: | TRIMIPRAMINE MALEATE at DailyMed |
![TRIMIPRAMINE MALEATE drug patent expirations Drug patent expirations by year for TRIMIPRAMINE MALEATE](/p/graph/s/t/TRIMIPRAMINE_MALEATE-patent-expirations.png)
![Drug Prices for TRIMIPRAMINE MALEATE](/p/graph/drug-price/TRIMIPRAMINE+MALEATE.png)
Pharmacology for TRIMIPRAMINE MALEATE
Drug Class | Tricyclic Antidepressant |
Medical Subject Heading (MeSH) Categories for TRIMIPRAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for TRIMIPRAMINE MALEATE
US Patents and Regulatory Information for TRIMIPRAMINE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breckenridge | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 208127-001 | Apr 15, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Usl Pharma | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 071283-001 | Dec 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Elite Labs Inc | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 077361-001 | Aug 2, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Usl Pharma | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 071284-001 | Dec 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Breckenridge | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 208127-002 | Apr 15, 2016 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |